Video interview: Psychedelics as tools for psychiatry and psychotherapy – Torsten Passie (Finnish subtitles)

What kinds of challenges does the medical utilization of psychedelics entail? What’s the difference between psycholytic and psychedelic therapy? Is the optimism towards psychedelic therapies unwarranted? Can MDMA assisted therapy lead to MDMA addiction? What are the effects of excessive MDMA use? Does a therapist working with altered states of consciousness need to have personal experience? What does the data say about microdosing? What kinds of career paths might lead towards one becoming a psychedelic therapist? What are the main problems related to current psychedelic therapy training programs?

Psychiatry and psychotherapy professor Torsten Passie from the Hannover Medical School has been researching psychedelics for a long time: his experience with the legal therapeutic use of psychedelics in Germany and Switzerland leads all the way to the eighties. Passie’s interest in the field was initiated by a spontaneous mystical experience that he found irritating. In his work, he’s mapped out threads such as the history of MDMA and the effects of microdosing, and his broad understanding of psychedelics has been called encyclopedic. In this newly published interview recorded in 2019, Passie discusses questions listed above and several others. The video includes Finnish subtitles.

• • • • •

If you have a professional interest in research on psychedelics or forms of psychedelic-assisted therapy, or you would like to otherwise information on psychedelic research in Finland, you can become a member of the Finnish Association for Psychedelic Research.

Comments are Disabled